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ABSTRACT
Aims & Objective: To isolate and diagnose the Uropathogens and its antibiotic sensitivity pattern in anti-natal
care patient suffering from Urinary tract Infections. Material and Methods: 150 samples were collected by
consent pregnant women between the age group of 18 to 40 years. A midstream clean catch is adequate, provided
by all pregnant women’s through given careful instructions. For enumeration of bacteria we perform standard
loop techniques method. The number of colonies counted or estimated, and this number used to calculate the
number of viable bacteria per ml of urine. The bacterial strains were identified by colonies character stick, gram
staining, morphological and biochemical character. The bacterial strains identification was done up to genus and
species level. The antibiotics sensitivity test of bacterial strains was done as per CLSI guidelines by Kirby-Baure
Disc Diffusion Methods. Results: The significant bactiurea was found in 50 patients among 150 patients used.
The  most  commonly  isolated  bacteria  was Escherichia  coli 23(40%) Klebsiellaaerogens 11 (22%)
Staphylococcus aureus 10 (20%) Pseudomonas aerugenosa 4(8%).The incidence of bacteriuria among in their
first pregnancy was 22.2%.The higher incidence of UTI in 2
nd and 3
rd trimester was found to have 31.4% & 40%.
These studies were showing high level of resistance to first line antibiotics such as Cotrimaxozole. Conclusion:
To minimizing the complication of the pregnant women should be educated about the physiology of pregnancy
clinical presentation includes asymptomatic bacteria, acute cystitis & pyelonephritis. Pregnant women should be
screened for asymptomatic bacteriuria by urine culture and treated with appropriate antibiotics. After the post
treatment pregnant women should be examine again to confirm post treatment urine sterility.
Keywords: Pregnancy, Antimicrobial, UTI, Antenatal, Uropathogens.
INTRODUCTION
Urinary Tract Infection is an infection caused by the
presence and growth of microorganism in the urinary
treat. Urinary  Tract Infection  is the  second  most
common  type  of  infection  that  affects  millions  of
people numbers times during life time. It is perhaps
the  single  most  common  bacterial infection  of
mankind.
1,2 Urinary  tract  including  the  organs  that
collect the store urine and release it from the body
which  include kidneys,  uterus, urinary  bladders
&urethra both in community & hospital settings and
have  been  reported  in  all  age  groups  in  both
sexes.
3UTI is  the second  most  common  cause  of
bacteremia in hospitalized patients.
4,5
Women tend to have UTI more often than man due to
the short and wider female urethra and its proximity
to anus. Bacteria may easily travel up to the urethra
and cause infection from the rectum
2, 5 moreover, the
main factors predisposing married women to bacteria
are pregnancy and sexual intercourse.
6The chances of
bacterial contamination  of the female  urethra
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increasing due to sexual activity. UTIs may cause in
women  because  bacteria  can  be  pushed into  the
urethra after intercourse. Once the bacteria may enter
the urethra they travel upward, causing infection in
the  urinary  bladder  and other  parts  of  the  urinary
tract.
The Pregnant women have increased risk for UTIs at
the  beginning  in  week  6
thof  gestations.
Approximately  90%  pregnant  women  develop
urethral  dilatation,  increased  bladder  volume  and
decrease bladder tone, along with decreased ureteral
tone  contribution  to  increased  urinary  stasis  and
ureter  vesicle reflux.
7 More than 70%  of  pregnant
women  develop  glycosuria, which  promote  the
bacterial growth in the urine. The increased level of
progesterone and  estrogens in  urine may  lead  to  a
decreased the ability of invading the bacteria. This
decreased ability may also cause by contract ureteral
tone.
8,9 These  factors  may  all present to  the
development of UTIs during pregnancy.
Significant bacteriuria may  exist  in  asymptomatic
patients.  In  1960s  Kass noted  the  subsequent  high
risk  of  developing  pyelonephritis  in  patients  with
asymptomatic bacteria. The significant bacteriuria has
been  historically  defined  by finding  more  than
10
5cfu/ml of urine.
10,11In recent studies the pregnant
women with acute dysuria have showed the presence
of  significant  bacteriuria  with  lower  colony
counts.
12,13
The sign and symptoms of UTI may be varying to
age, sex and location of the infection. The urine may
develop  an  unpleasant odour.  Women  feel lower
abdominal discomfort and experience sensations like
there  bladder  is  full.  Women  may have  an  STD
(sexual  transmitted  disease)  and  urethral  infection
may also complain of a vaginal discharge. Dysuria,
frequency and urgency, other symptoms may include
rectal,  testicular,  penile  or  abdominal  pain may  be
complained by man.
MATERIAL AND METHODS
Study Area: This study was done in Department of
Microbiology  at  Teerthankar Mahaveer  Medical
College,  Moradabad  (U.P.,  India)  in  2011  to  2012
after the approval of Institutional Ethics committee. A
total  of  150 urine  sample  were  collected  from
pregnant women between the age group of 18 to 40
years. The  urine  sample was  obtained  by  informed
consent  of  the  pregnant  women.The  Demographic
and clinical information of the subjects were obtained
by  chart  abstraction  and  recorded  on  prepare  data
collection form.
Sample  collection: Midstream clean  catchurine is
requisite; the samples were collect by all patients by
given instructions. The instructions are as follows:
 First the labia spread with one hand and then.
 With  the  other  hand,  wipe  the  urethral  meatus
downward  toward  the  rectum with  the help  of
towelette, and then discard the towelette.
 Then release initial portion of urine and collect the
second  part  of  urine  in void mouth  sterile
containers approx 10-15 ml and then release the
excess urine in to the toilet.
The clean catch specimen should not be reduces or
eliminate the possibility of cross- contamination from
the urethra and vagina. More than two organisms in a
culture usually indicate a contaminated specimen.
Culture,  Enumeration,  Isolation  &  identification
of  Uropathogens: The  culture  was  done  on
MacConkey  Agar,  Sheep  Blood  Agar  and  Mueller
Hinton Agar was used for Antibiotics sensitivity. For
enumeration  of  bacteria  we  perform  standard  loop
techniques method. An inoculating loop of standard
dimension is used to take up a small, approximately
fixed  and  known  volume  of  mixed  un-centrifuged
urine  and  spread  it  over  a  plate  of  agar  culture
medium.  The  plate  is  incubated,  the  number  of
colonies counted or estimated, and this number used
to calculate the number of viable bacteria per ml of
urine. Thus, if a 0.004 ml loop full of urine yields 400
colonies, the count per ml will be 10
5, (250×1,00,000)
or just indicative of significant bacteriuria.
The  bacterial  strains  were  identified  by  Colonies
character  stick,  Gram  Staining,  Morphological and
Biochemical  character.  The  bacterial  strains
identification was done up to genus and species level.
The antibiotics sensitivity test of bacterial strains was
done  as  per  CLSI
14guidelines  by  Kirby-Baure  Disc
Diffusion Methods
14.
RESULTS
Table 1: Showed Incidence of UTI in relation of
age Distribution of Pregnant women
Age Group No. of Tested No. of Positive
21-25 40 7 (17.5%)
26-30 45 15 (33.3%)
31-35 35 4 (11.4%)
36-40 30 24 (80.0%)
Total 150 50 (33.3%)311
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Table 2: Incidence of UTI by No. of Pregnancy.
Parity No.of tested No.of Positive
1st Pregnancy 45 10 (22.2%)
2nd Pregnancy 55 15 (27.3%)
3rd & Above 50 25(50.0%)
Table  3:  Frequency  of  UTI  in  different  gestational
periods
Age of Pregnancy
(In Months)
No.  of
Tested
No.  of
Positive
3 10 0(0.0%)
4 25 2 (8.0%)
5 15 5(33.3%)
6 30 15 (50.0%)
7 30 13(43.3%)
8 25 10(40%)
9 15 5(33.3%)
Table 4: Various bacteria isolated from Urine samples
Isolates No.of positive Samples
Eschericheia coli 23 (46%)
Klebsiella spp. 11 (22%)
Pseudomonas aeruginosa 4 (8%)
Staphylococcus aureus 10 (20%)
mixed Culture 2 (4%)
Total 50
Table 5: Antibiotics Pattern of E coli (n=23)
Name of Antibiotic Sensitivity
Polymyxin B (300unit) 19(82.6%)
Nitrofurantoin (300µg) 17 (73.9%)
Levofloxacin (5µg) 15 (65.2%)
Chloroamphenicol (30µg) 13 (56.5%)
Amikacin (30µg) 12 (52.2%)
Cefoperazone (75µg) 11 (47.8%)
Ampicillin (10µg) 10 (43.5%)
Gentamicin (10µg) 8 (34.8%)
Norfloxacin (10µg) 7 (30.4%)
Co-Trimoxazole (25µg 6 (26.1%)
Table 6: Antibiotics Pattern of Klebsiellaaerogens n=11
Name of Antibiotic Sensitivity
Ciprofloxacin(5µg) 10 (90.9%)
Ceftazidime(30µg) 9 (81.8%)
eCefotaxime(30µg) 9 (81.8%)
Chloroamphecol(30µg) 8 (72.7%)
Gentamicin(10µg) 7 (63.6%)
Levofloxacin(5µg) 5 (45.5%)
Ampicillin(10µg) 3 (27.3%)
Norfloxacin(10µg) 2 (18.2%)
Meropenum(10µg) 2 (18.2%)
Co-Trimoxazole(25µg) 1 (9.1%)
Table 7: Showed Antibiotics Pattern of staphylococcus
aureus n=10
Name of Antibiotic Sensitivity
Nitrofurantoin (300µg) 9 (90.0%)
Levofloxacin (5µg) 9 (90.0%)
Ciprofloxacin (5µg) 8 (80.0%)
Gentamicin (10µg) 8 (80.0%)
Ceftazidime (30µg) 7 (70.0%)
Imipenam (10µg) 7 (70.0%)
Cefoperazone (75/10 µg) 6 (60.0%)
Tobramycin (10µg) 5 (50.0%)
Amikacin (10µg) 5 (50.0%)
Norfloxacin (10µg) 3 (30.0%)
Table 1: Showed the higher percentage of UTIs was
obtained in the age groups of 36-40 (80.0%) years
followed  by  the age  groups  26-30 (33.3%). The
highest  number  of  bacterial  isolates  was  found  in
subject  of  36-40  years  followed  by  26-30  years.
Comparatively,  lower number  of  bacterial  isolates
was obtained from age groups 21-25 and 31-35 years.
Table  2: Showed  the  highest  percentage  of  UTIs
occurrence is 50% in there 3
rd and above pregnancy
followed by 27.3% in 2
nd pregnancy and the lowest
incidence of UTIs 22.2% in the 1
st pregnancy.
Table  3:  Showed  the  prevalence  of  UTIs  by
gestational  age  (age  of  pregnancy)  revealed  that
women in the 6
th and 7
th months of their pregnancy
had  the  highest  prevalence  of  50.0%  and  43.0%
respectively while women in the early month of their
pregnancy  had  no  specific bacterial  growth and
shows no sign of UTIs.
Table 4: Out of 50 isolates, Gram negative bacteria
were  more  frequently  then  gram  positive  bacteria.
These  include Escherichia  coli (46%),
Klebsiellaaerogens (22%), Pseudomonasaeruginosa
(8%).  Gram  positive  bacteria  account  with
Staphylococcus aureus (20%). The rate of isolation of
Klebsiellaaerogens and Staphylococcus  aureus was
higher in spcimen collected from pregnant women.
DISCUSSION
During the period from January 2011 to December
2012a  total  of  150  urine  specimens  were  collected
from  pregnant  women  and  processed.  Significant
bacteria colony forming units (cfu) 10
5 was found in
50  patient  among  150  patients  used.  The  most
commonly isolated bacteria was Escherichia coli 23
(40%) Klebsiellaaerogenes 11 (22%) Staphylococcus312
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aureus 10 (20%) Pseudomonas aerogenes 4 (8%) and
mix culture Klebesiella& Staphylococcus 2 (4%). In
pregnant study out of 50 positive urine samples, gram
negative bacteria were more prevalent 78% then gram
positive  bacteria  22%.  Which  was  similar  from
previous study gram negative bacteria (61.9%) then
gram  positive  bacteria  (38.1%), (Sabrina J.
2009).
15Thesimilar finding have been also reported by
Bloomberg  et.  Al  2005as  well  as  elsewhere Gebre
Selassie,  1998,  Delzell&Lefevre,  2000;  Nicolle,
2001; Schnarr&Smaill, 2008.
16-20
The incidence of bacteria among women in their first
pregnancy  is  22.2%. This  figure  is  higher  than  the
prevalent role of 2-9% reported by Nicolle (2003)
21
and lower than in a similar study on pregnant women
the  number  of  pregnancy is  one  of  the  possible
factors affecting the incidence & prevalence rate of
UTIs among women.
22 Present study also showed that
women in their pregnancy had the higher incidence of
UTI  while  women  on  their  early  month  of  the
pregnancy had no specific bacteria growth & shows
no signs of UTIs.
In  the  present  study,  women  in  their  2
nd and  3
rd
trimester were found to have the higher incidence of
UTI 31.4% & 40% respectively, but it was lower than
the previous study in 2
nd trimester 41.4% and in 3
rd
trimester 55% (Okonko et.al 2009)
22
This study showed high levels of resistance to first
line  antibiotic such  ascotrimaxozole.  These  finding
correlated with finding from previous studies (Gupta
et. Al, Arrendondo – Garcia, et al.
23-25
CONCLUSION
It is obvious from this limited study that significant
bacteria  in  pregnancy  are  common  and  a  serious
causes  of  maternal  and  perinatal  morbidity  and
mortality.  To minimize  the  complication  of
pregnancies regular antenatal care showed be taken.
The pregnant women should be educated about the
physiology  of  pregnancy  clinical  presentation
includes asymptomatic bacteria.
Acute  cystitis  and  pyelonephritis pregnant  women
should be checked for asymptomatic bacteria by urine
culture  and treated with  appropriate  antibiotics.  All
women  should  be confirming  post  treatment  urine
sterility by reviewing the urine culture. When intake
an  antibiotics the  pharmacokinetics  and
bioavailability  of  the  individual  drug  in  pregnancy
must be considered alone with the resistance profiles
of microorganism in the local antenatal population. It
is  established  a  vital  use  of  treatment  with safety
profile, without teratogenic risks.
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